{"transactions":[{"id":4620410,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-17T01:13:38.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":5000,"price":9.1,"value":45500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 06-15-2026"}],"balance_after":54750,"source":{"system":"sec-edgar","filing":"0001437749-26-030597","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1589597/000143774926030597/rdgdoc.xml","form_type":"4"}},{"id":4620393,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-09-17T01:06:16.000Z","date":"2026-09-14","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option is fully vested."}],"balance_after":50000,"derivative":{"exercise_price":2.93,"expiration_date":"2032-07-28","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-26-030593","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1827015/000143774926030593/rdgdoc.xml","form_type":"4"}},{"id":4620392,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-17T01:06:16.000Z","date":"2026-09-14","kind":"sale","planned":true,"acquired":false,"shares":62150,"price":9.123,"value":566994.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 06-15-2026"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.03 to $9.2, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":56700,"source":{"system":"sec-edgar","filing":"0001437749-26-030593","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1827015/000143774926030593/rdgdoc.xml","form_type":"4"}},{"id":4620391,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-09-17T01:06:16.000Z","date":"2026-09-14","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":2.93,"value":146500.0,"ownership":{"direct":true},"balance_after":118850,"source":{"system":"sec-edgar","filing":"0001437749-26-030593","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1827015/000143774926030593/rdgdoc.xml","form_type":"4"}},{"id":712553,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-07-09T00:21:27.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":44058,"price":8.263,"value":364051.254,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020."}],"balance_after":7261671,"source":{"system":"sec-edgar","filing":"0001437749-26-023079","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926023079/rdgdoc.xml","form_type":"4"}},{"id":712552,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-07-09T00:19:45.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":8460,"price":8.263,"value":69904.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."}],"balance_after":196841,"source":{"system":"sec-edgar","filing":"0001437749-26-023078","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926023078/rdgdoc.xml","form_type":"4"}},{"id":712550,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-09T00:18:34.000Z","date":"2026-07-06","kind":"sale","planned":true,"acquired":false,"shares":9386,"price":8.263,"value":77556.518,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."}],"balance_after":230637,"source":{"system":"sec-edgar","filing":"0001437749-26-023077","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926023077/rdgdoc.xml","form_type":"4"}},{"id":737667,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:16:34.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":10800,"price":7.1989,"value":77748.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 03-12-2025"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":59750,"source":{"system":"sec-edgar","filing":"0001437749-26-020709","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020709/rdgdoc.xml","form_type":"4"}},{"id":737666,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:16:34.000Z","date":"2026-06-11","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":70550,"source":{"system":"sec-edgar","filing":"0001437749-26-020709","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020709/rdgdoc.xml","form_type":"4"}},{"id":737840,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38184,"kind":"person","name":"Stuglik Brian M","position":1,"cik":"0001716328","reported_name":"Stuglik Brian M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:14:49.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":8100,"price":7.1989,"value":58311.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 03-12-2025"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":113858,"source":{"system":"sec-edgar","filing":"0001437749-26-020708","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1716328/000143774926020708/rdgdoc.xml","form_type":"4"}},{"id":737839,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38184,"kind":"person","name":"Stuglik Brian M","position":1,"cik":"0001716328","reported_name":"Stuglik Brian M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:14:49.000Z","date":"2026-06-11","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":121958,"source":{"system":"sec-edgar","filing":"0001437749-26-020708","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716328/000143774926020708/rdgdoc.xml","form_type":"4"}},{"id":737665,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:13:36.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":27000,"price":7.1967,"value":194310.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 03-12-2025"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001437749-26-020706","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020706/rdgdoc.xml","form_type":"4"}},{"id":737664,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:13:36.000Z","date":"2026-06-11","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001437749-26-020706","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020706/rdgdoc.xml","form_type":"4"}},{"id":737663,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:12:13.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":81000,"source":{"system":"sec-edgar","filing":"0001437749-26-020705","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020705/rdgdoc.xml","form_type":"4"}},{"id":737662,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:10:21.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":7.218,"value":158796.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 03-12-2025"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":58322,"source":{"system":"sec-edgar","filing":"0001437749-26-020704","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020704/rdgdoc.xml","form_type":"4"}},{"id":737661,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:10:21.000Z","date":"2026-06-11","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":80322,"source":{"system":"sec-edgar","filing":"0001437749-26-020704","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020704/rdgdoc.xml","form_type":"4"}},{"id":737660,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38120,"kind":"person","name":"Dorval Allison","position":1,"cik":"0001625110","reported_name":"Dorval Allison","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:09:07.000Z","date":"2026-06-12","kind":"sale","planned":true,"acquired":false,"shares":11610,"price":7.1989,"value":83579.229,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Adoption date of referenced 10b5-1(c) plan is: 03-12-2025"},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.98 to $7.32, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":90780,"source":{"system":"sec-edgar","filing":"0001437749-26-020703","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020703/rdgdoc.xml","form_type":"4"}},{"id":737659,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38120,"kind":"person","name":"Dorval Allison","position":1,"cik":"0001625110","reported_name":"Dorval Allison","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:09:07.000Z","date":"2026-06-11","kind":"grant","planned":true,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":102390,"source":{"system":"sec-edgar","filing":"0001437749-26-020703","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020703/rdgdoc.xml","form_type":"4"}},{"id":737658,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-16T00:07:40.000Z","date":"2026-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":68850,"source":{"system":"sec-edgar","filing":"0001437749-26-020702","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926020702/rdgdoc.xml","form_type":"4"}},{"id":890538,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-21T01:29:13.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":227474,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to the Reporting Person's continued status as an Employee of the Company, the Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares of Common Stock subject thereto on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to acceleration in certain events."}],"balance_after":227474,"derivative":{"exercise_price":6.68,"expiration_date":"2036-02-17","underlying":"Common Stock","underlying_shares":227474},"source":{"system":"sec-edgar","filing":"0001437749-26-004948","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926004948/rdgdoc.xml","form_type":"4"}},{"id":890537,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-02-21T01:29:13.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":159778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the grant of Restricted Stock Units ('RSUs\"). Subject to the Reporting Person's continued status as an Employee of the Company, the RSUs shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to acceleration in certain events."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of Restricted Stock Units ('RSUs\"). Subject to the Reporting Person's continued status as an Employee of the Company, the RSUs shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to acceleration in certain events."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the grant of Restricted Stock Units ('RSUs\"). Subject to the Reporting Person's continued status as an Employee of the Company, the RSUs shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to acceleration in certain events."}],"balance_after":7305729,"source":{"system":"sec-edgar","filing":"0001437749-26-004948","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926004948/rdgdoc.xml","form_type":"4"}},{"id":890534,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-21T01:28:40.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":70321,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service with the Company through the applicable vesting date."}],"balance_after":70321,"derivative":{"exercise_price":6.68,"expiration_date":"2036-02-17","underlying":"Common Stock","underlying_shares":70321},"source":{"system":"sec-edgar","filing":"0001437749-26-004947","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926004947/rdgdoc.xml","form_type":"4"}},{"id":890533,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-02-21T01:28:40.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":49394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service with the Company through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service with the Company through the applicable vesting date."}],"balance_after":205301,"source":{"system":"sec-edgar","filing":"0001437749-26-004947","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926004947/rdgdoc.xml","form_type":"4"}},{"id":890532,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-21T01:28:04.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":66541,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to the Reporting Person's  continued service with the Company through the applicable vesting date."}],"balance_after":66541,"derivative":{"exercise_price":6.68,"expiration_date":"2036-02-17","underlying":"Common Stock","underlying_shares":66541},"source":{"system":"sec-edgar","filing":"0001437749-26-004946","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926004946/rdgdoc.xml","form_type":"4"}},{"id":890531,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-21T01:28:04.000Z","date":"2026-02-18","kind":"grant","planned":false,"acquired":true,"shares":46739,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service with the Company through the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2026, January 1, 2027, July 1, 2027 and January 1, 2028, subject to the Reporting Person's continued service with the Company through the applicable vesting date."}],"balance_after":240023,"source":{"system":"sec-edgar","filing":"0001437749-26-004946","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926004946/rdgdoc.xml","form_type":"4"}},{"id":943132,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-09T01:27:45.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":18012,"price":5.879,"value":105892.548,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-17-2020"}],"balance_after":7145951,"source":{"system":"sec-edgar","filing":"0001437749-26-000924","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926000924/rdgdoc.xml","form_type":"4"}},{"id":943131,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2026-01-09T01:27:45.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":16938,"price":5.844,"value":98985.672,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-17-2020"}],"balance_after":7163963,"source":{"system":"sec-edgar","filing":"0001437749-26-000924","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926000924/rdgdoc.xml","form_type":"4"}},{"id":943130,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-09T01:15:27.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":5014,"price":5.879,"value":29477.306,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-14-2020"}],"balance_after":155907,"source":{"system":"sec-edgar","filing":"0001437749-26-000922","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926000922/rdgdoc.xml","form_type":"4"}},{"id":943129,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-01-09T01:15:27.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":3973,"price":5.844,"value":23218.212,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-14-2020"}],"balance_after":160921,"source":{"system":"sec-edgar","filing":"0001437749-26-000922","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926000922/rdgdoc.xml","form_type":"4"}},{"id":943128,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-09T01:14:50.000Z","date":"2026-01-07","kind":"sale","planned":true,"acquired":false,"shares":6405,"price":5.879,"value":37654.995,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-14-2020"}],"balance_after":193284,"source":{"system":"sec-edgar","filing":"0001437749-26-000921","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926000921/rdgdoc.xml","form_type":"4"}},{"id":943127,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-09T01:14:50.000Z","date":"2026-01-06","kind":"sale","planned":true,"acquired":false,"shares":4540,"price":5.844,"value":26531.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-14-2020"}],"balance_after":199689,"source":{"system":"sec-edgar","filing":"0001437749-26-000921","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774926000921/rdgdoc.xml","form_type":"4"}},{"id":1000091,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-11-13T21:41:21.000Z","date":"2025-11-11","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":4.8614,"value":97228.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.82 to $4.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001437749-25-034874","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925034874/rdgdoc.xml","form_type":"4"}},{"id":1083306,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-07-22T23:51:39.000Z","date":"2025-07-18","kind":"sale","planned":true,"acquired":false,"shares":27000,"price":3.367,"value":90909.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03-11-2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":41850,"source":{"system":"sec-edgar","filing":"0001437749-25-023268","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925023268/rdgdoc.xml","form_type":"4"}},{"id":1089226,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-11T00:56:09.000Z","date":"2025-07-09","kind":"sale","planned":true,"acquired":false,"shares":3935,"price":3.535,"value":13910.225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-14-2020"}],"balance_after":204229,"source":{"system":"sec-edgar","filing":"0001437749-25-022551","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925022551/rdgdoc.xml","form_type":"4"}},{"id":1089225,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-07-11T00:56:09.000Z","date":"2025-07-08","kind":"sale","planned":true,"acquired":false,"shares":5587,"price":3.533,"value":19738.871,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-14-2020"}],"balance_after":208164,"source":{"system":"sec-edgar","filing":"0001437749-25-022551","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925022551/rdgdoc.xml","form_type":"4"}},{"id":1089221,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-11T00:52:14.000Z","date":"2025-07-09","kind":"sale","planned":true,"acquired":false,"shares":3443,"price":3.535,"value":12171.005,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-14-2020"}],"balance_after":164894,"source":{"system":"sec-edgar","filing":"0001437749-25-022549","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925022549/rdgdoc.xml","form_type":"4"}},{"id":1089220,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-07-11T00:52:14.000Z","date":"2025-07-08","kind":"sale","planned":true,"acquired":false,"shares":4374,"price":3.533,"value":15453.342,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-14-2020"}],"balance_after":168337,"source":{"system":"sec-edgar","filing":"0001437749-25-022549","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925022549/rdgdoc.xml","form_type":"4"}},{"id":1089223,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-11T00:49:15.000Z","date":"2025-07-09","kind":"sale","planned":true,"acquired":false,"shares":21580,"price":3.535,"value":76285.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-17-2020"}],"balance_after":7180901,"source":{"system":"sec-edgar","filing":"0001437749-25-022547","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925022547/rdgdoc.xml","form_type":"4"}},{"id":1089222,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-07-11T00:49:15.000Z","date":"2025-07-08","kind":"sale","planned":true,"acquired":false,"shares":25592,"price":3.533,"value":90416.536,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 12-17-2020"}],"balance_after":7202481,"source":{"system":"sec-edgar","filing":"0001437749-25-022547","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925022547/rdgdoc.xml","form_type":"4"}},{"id":1107819,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-17T23:55:12.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":10800,"price":3.4,"value":36720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03/12/2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":43550,"source":{"system":"sec-edgar","filing":"0001437749-25-020721","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020721/rdgdoc.xml","form_type":"4"}},{"id":1108030,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38184,"kind":"person","name":"Stuglik Brian M","position":1,"cik":"0001716328","reported_name":"Stuglik Brian M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-17T23:52:20.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":8100,"price":3.39,"value":27459.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03/12/2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":94958,"source":{"system":"sec-edgar","filing":"0001437749-25-020719","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716328/000143774925020719/rdgdoc.xml","form_type":"4"}},{"id":1107818,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-17T23:49:43.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":27000,"price":3.4,"value":91800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03/12/2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001437749-25-020717","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020717/rdgdoc.xml","form_type":"4"}},{"id":1107817,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-17T23:46:13.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":3.4,"value":74800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03/12/2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":53322,"source":{"system":"sec-edgar","filing":"0001437749-25-020715","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020715/rdgdoc.xml","form_type":"4"}},{"id":1107816,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38120,"kind":"person","name":"Dorval Allison","position":1,"cik":"0001625110","reported_name":"Dorval Allison","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-17T23:43:40.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":11610,"price":3.4,"value":39474.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03/12/2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":75390,"source":{"system":"sec-edgar","filing":"0001437749-25-020713","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020713/rdgdoc.xml","form_type":"4"}},{"id":1107815,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-17T23:41:27.000Z","date":"2025-06-13","kind":"sale","planned":true,"acquired":false,"shares":12150,"price":3.4,"value":41310.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) plan is: 03-11-2025"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.34 to $3.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":68850,"source":{"system":"sec-edgar","filing":"0001437749-25-020711","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020711/rdgdoc.xml","form_type":"4"}},{"id":1111411,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T00:19:53.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":74000,"source":{"system":"sec-edgar","filing":"0001437749-25-020363","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020363/rdgdoc.xml","form_type":"4"}},{"id":1111410,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T00:18:03.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001437749-25-020362","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020362/rdgdoc.xml","form_type":"4"}},{"id":1111409,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T00:16:24.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":75322,"source":{"system":"sec-edgar","filing":"0001437749-25-020361","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020361/rdgdoc.xml","form_type":"4"}},{"id":1111407,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38120,"kind":"person","name":"Dorval Allison","position":1,"cik":"0001625110","reported_name":"Dorval Allison","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T00:14:55.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":87000,"source":{"system":"sec-edgar","filing":"0001437749-25-020360","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020360/rdgdoc.xml","form_type":"4"}},{"id":1111742,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38184,"kind":"person","name":"Stuglik Brian M","position":1,"cik":"0001716328","reported_name":"Stuglik Brian M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T00:12:33.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":103058,"source":{"system":"sec-edgar","filing":"0001437749-25-020359","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716328/000143774925020359/rdgdoc.xml","form_type":"4"}},{"id":1111408,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T00:11:24.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":54350,"source":{"system":"sec-edgar","filing":"0001437749-25-020358","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020358/rdgdoc.xml","form_type":"4"}},{"id":1111406,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-06-14T00:10:12.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":81000,"source":{"system":"sec-edgar","filing":"0001437749-25-020357","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925020357/rdgdoc.xml","form_type":"4"}},{"id":1273702,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T23:58:40.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":85067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Optionee's continued service with the Company through the applicable vesting date."}],"balance_after":85067,"derivative":{"exercise_price":2.78,"expiration_date":"2035-02-06","underlying":"Common Stock","underlying_shares":85067},"source":{"system":"sec-edgar","filing":"0001437749-25-003461","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925003461/rdgdoc.xml","form_type":"4"}},{"id":1273701,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-11T23:58:40.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":61456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Grantee's continued service with the Company through the applicable vesting date."}],"balance_after":213751,"source":{"system":"sec-edgar","filing":"0001437749-25-003461","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925003461/rdgdoc.xml","form_type":"4"}},{"id":1273700,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T23:53:52.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":66604,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Optionee's continued service with the Company through the applicable vesting date."}],"balance_after":66604,"derivative":{"exercise_price":2.78,"expiration_date":"2035-02-06","underlying":"Common Stock","underlying_shares":66604},"source":{"system":"sec-edgar","filing":"0001437749-25-003456","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925003456/rdgdoc.xml","form_type":"4"}},{"id":1273699,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-02-11T23:53:52.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":48117,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Grantee's continued service with the Company through the applicable vesting date."}],"balance_after":172711,"source":{"system":"sec-edgar","filing":"0001437749-25-003456","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925003456/rdgdoc.xml","form_type":"4"}},{"id":1273698,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T23:51:06.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":274622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares (as defined in the Plan) subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to acceleration in certain events."}],"balance_after":274622,"derivative":{"exercise_price":2.78,"expiration_date":"2035-02-06","underlying":"Common Stock","underlying_shares":274622},"source":{"system":"sec-edgar","filing":"0001437749-25-003454","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925003454/rdgdoc.xml","form_type":"4"}},{"id":1273697,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-02-11T23:51:06.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":198399,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to acceleration in certain events."}],"balance_after":7228073,"source":{"system":"sec-edgar","filing":"0001437749-25-003454","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925003454/rdgdoc.xml","form_type":"4"}},{"id":1274114,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":83367,"kind":"person","name":"Ludwig Jeffrey Jerome","position":1,"cik":"0001807133","reported_name":"Ludwig Jeffrey Jerome","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-11T18:55:59.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":66221,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Optionee's continued service with the Company through the applicable vesting date."}],"balance_after":66221,"derivative":{"exercise_price":2.78,"expiration_date":"2035-02-06","underlying":"Common Stock","underlying_shares":66221},"source":{"system":"sec-edgar","filing":"0001437749-25-003459","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807133/000143774925003459/rdgdoc.xml","form_type":"4"}},{"id":1274113,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":83367,"kind":"person","name":"Ludwig Jeffrey Jerome","position":1,"cik":"0001807133","reported_name":"Ludwig Jeffrey Jerome","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-02-11T18:55:59.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":47841,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2025, January 1, 2026, July 1, 2026 and January 1, 2027, subject to the Grantee's continued service with the Company through the applicable vesting date."}],"balance_after":156792,"source":{"system":"sec-edgar","filing":"0001437749-25-003459","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807133/000143774925003459/rdgdoc.xml","form_type":"4"}},{"id":1314223,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-01-04T00:33:40.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":10227,"price":3.1517,"value":32232.4359,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":152295,"source":{"system":"sec-edgar","filing":"0001437749-25-000365","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925000365/rdgdoc.xml","form_type":"4"}},{"id":1314224,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2025-01-04T00:28:03.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":8633,"price":3.1517,"value":27208.6261,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":124594,"source":{"system":"sec-edgar","filing":"0001437749-25-000361","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925000361/rdgdoc.xml","form_type":"4"}},{"id":1314222,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2025-01-04T00:12:10.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":33841,"price":3.1517,"value":106656.6797,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":7029674,"source":{"system":"sec-edgar","filing":"0001437749-25-000359","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925000359/rdgdoc.xml","form_type":"4"}},{"id":1315051,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":83367,"kind":"person","name":"Ludwig Jeffrey Jerome","position":1,"cik":"0001807133","reported_name":"Ludwig Jeffrey Jerome","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2025-01-03T19:31:31.000Z","date":"2025-01-02","kind":"sale","planned":true,"acquired":false,"shares":9437,"price":3.1517,"value":29742.5929,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.11 to $3.2101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":108951,"source":{"system":"sec-edgar","filing":"0001437749-25-000363","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807133/000143774925000363/rdgdoc.xml","form_type":"4"}},{"id":1434731,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-08-14T01:09:49.000Z","date":"2024-08-12","kind":"sale","planned":false,"acquired":false,"shares":23358,"price":3.4877,"value":81465.6966,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.4201 to $3.5501, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Corrects the amount that was erroneously reported as held in the Form 4 filed on June 21, 2024 with the Securities and Exchange Commission."}],"balance_after":47000,"source":{"system":"sec-edgar","filing":"0001437749-24-026536","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924026536/rdgdoc.xml","form_type":"4"}},{"id":1451727,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-18T23:11:49.000Z","date":"2024-07-17","kind":"sale","planned":true,"acquired":false,"shares":4156,"price":3.7011,"value":15381.7716,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":162522,"source":{"system":"sec-edgar","filing":"0001437749-24-023022","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924023022/rdgdoc.xml","form_type":"4"}},{"id":1451726,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-18T22:57:18.000Z","date":"2024-07-17","kind":"sale","planned":true,"acquired":false,"shares":3637,"price":3.7011,"value":13460.9007,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":133227,"source":{"system":"sec-edgar","filing":"0001437749-24-023017","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924023017/rdgdoc.xml","form_type":"4"}},{"id":1451725,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-18T22:50:39.000Z","date":"2024-07-17","kind":"sale","planned":true,"acquired":false,"shares":21920,"price":3.7011,"value":81128.112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":7063515,"source":{"system":"sec-edgar","filing":"0001437749-24-023014","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924023014/rdgdoc.xml","form_type":"4"}},{"id":1451872,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":83367,"kind":"person","name":"Ludwig Jeffrey Jerome","position":1,"cik":"0001807133","reported_name":"Ludwig Jeffrey Jerome","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-18T19:06:54.000Z","date":"2024-07-17","kind":"sale","planned":true,"acquired":false,"shares":2598,"price":3.7011,"value":9615.4578,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.6001 to $3.8901, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":118388,"source":{"system":"sec-edgar","filing":"0001437749-24-023020","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807133/000143774924023020/rdgdoc.xml","form_type":"4"}},{"id":1462606,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-07-03T01:22:50.000Z","date":"2024-07-02","kind":"sale","planned":true,"acquired":false,"shares":5295,"price":3.2685,"value":17306.7075,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":166678,"source":{"system":"sec-edgar","filing":"0001437749-24-022067","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924022067/rdgdoc.xml","form_type":"4"}},{"id":1462605,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-07-03T01:15:44.000Z","date":"2024-07-02","kind":"sale","planned":true,"acquired":false,"shares":4349,"price":3.2685,"value":14214.7065,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":136864,"source":{"system":"sec-edgar","filing":"0001437749-24-022063","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924022063/rdgdoc.xml","form_type":"4"}},{"id":1462604,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-07-03T01:10:43.000Z","date":"2024-07-02","kind":"sale","planned":true,"acquired":false,"shares":18885,"price":3.2685,"value":61725.6225,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":7085435,"source":{"system":"sec-edgar","filing":"0001437749-24-022061","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924022061/rdgdoc.xml","form_type":"4"}},{"id":1463216,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":83367,"kind":"person","name":"Ludwig Jeffrey Jerome","position":1,"cik":"0001807133","reported_name":"Ludwig Jeffrey Jerome","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-07-02T21:19:19.000Z","date":"2024-07-02","kind":"sale","planned":true,"acquired":false,"shares":6051,"price":3.2685,"value":19777.6935,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2601 to $3.3101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":120986,"source":{"system":"sec-edgar","filing":"0001437749-24-022065","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807133/000143774924022065/rdgdoc.xml","form_type":"4"}},{"id":1471918,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-22T01:27:25.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":27350,"source":{"system":"sec-edgar","filing":"0001437749-24-021024","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021024/rdgdoc.xml","form_type":"4"}},{"id":1472105,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38184,"kind":"person","name":"Stuglik Brian M","position":1,"cik":"0001716328","reported_name":"Stuglik Brian M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-22T01:25:20.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":76058,"source":{"system":"sec-edgar","filing":"0001437749-24-021022","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716328/000143774924021022/rdgdoc.xml","form_type":"4"}},{"id":1471917,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-22T01:22:50.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":27000,"source":{"system":"sec-edgar","filing":"0001437749-24-021020","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021020/rdgdoc.xml","form_type":"4"}},{"id":1471916,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38121,"kind":"person","name":"MILLER MICHAEL PATRICK","position":1,"cik":"0001236514","reported_name":"MILLER MICHAEL PATRICK","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-22T01:21:21.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":95358,"source":{"system":"sec-edgar","filing":"0001437749-24-021018","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021018/rdgdoc.xml","form_type":"4"}},{"id":1471915,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-22T01:19:26.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":48322,"source":{"system":"sec-edgar","filing":"0001437749-24-021016","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021016/rdgdoc.xml","form_type":"4"}},{"id":1471914,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38120,"kind":"person","name":"Dorval Allison","position":1,"cik":"0001625110","reported_name":"Dorval Allison","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-22T01:17:56.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":60000,"source":{"system":"sec-edgar","filing":"0001437749-24-021014","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021014/rdgdoc.xml","form_type":"4"}},{"id":1471911,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38119,"kind":"person","name":"Cesano Alessandra","position":1,"cik":"0001827015","reported_name":"Cesano Alessandra","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-22T01:16:40.000Z","date":"2024-06-18","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":54000,"source":{"system":"sec-edgar","filing":"0001437749-24-021012","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924021012/rdgdoc.xml","form_type":"4"}},{"id":1477155,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":20321,"kind":"person","name":"WILSON TROY EDWARD","position":1,"cik":"0001589597","reported_name":"WILSON TROY EDWARD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-17T23:27:35.000Z","date":"2024-06-13","kind":"sale","planned":true,"acquired":false,"shares":27000,"price":3.3297,"value":89901.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2801 to $3.5801, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":350,"source":{"system":"sec-edgar","filing":"0001437749-24-020574","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924020574/rdgdoc.xml","form_type":"4"}},{"id":1477343,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38184,"kind":"person","name":"Stuglik Brian M","position":1,"cik":"0001716328","reported_name":"Stuglik Brian M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-17T23:25:08.000Z","date":"2024-06-13","kind":"sale","planned":true,"acquired":false,"shares":9900,"price":3.3867,"value":33528.33,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-16-2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.3001 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":49058,"source":{"system":"sec-edgar","filing":"0001437749-24-020572","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1716328/000143774924020572/rdgdoc.xml","form_type":"4"}},{"id":1477154,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38122,"kind":"person","name":"Senderowicz Adrian","position":1,"cik":"0001616230","reported_name":"Senderowicz Adrian","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-17T23:23:24.000Z","date":"2024-06-13","kind":"sale","planned":true,"acquired":false,"shares":27000,"price":3.3266,"value":89818.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.2801 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001437749-24-020570","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924020570/rdgdoc.xml","form_type":"4"}},{"id":1477153,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31814,"kind":"person","name":"MOYES JAY M","position":1,"cik":"0001191062","reported_name":"MOYES JAY M","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-17T23:21:26.000Z","date":"2024-06-13","kind":"sale","planned":true,"acquired":false,"shares":22000,"price":3.3394,"value":73466.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.3001 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":21322,"source":{"system":"sec-edgar","filing":"0001437749-24-020568","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924020568/rdgdoc.xml","form_type":"4"}},{"id":1477152,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":38120,"kind":"person","name":"Dorval Allison","position":1,"cik":"0001625110","reported_name":"Dorval Allison","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-06-17T23:18:53.000Z","date":"2024-06-13","kind":"sale","planned":true,"acquired":false,"shares":11000,"price":3.3724,"value":37096.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 03-06-2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.3001 to $3.5401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001437749-24-020566","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924020566/rdgdoc.xml","form_type":"4"}},{"id":1568255,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-20T01:01:40.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":9047,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects supplemental annual equity awards due to an administrative error in the calculations used to determine the original number of shares underlying the annual equity awards."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events."}],"balance_after":9047,"derivative":{"exercise_price":5,"expiration_date":"2034-03-14","underlying":"Common Stock","underlying_shares":9047},"source":{"system":"sec-edgar","filing":"0001437749-24-008575","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924008575/rdgdoc.xml","form_type":"4"}},{"id":1568254,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-03-20T01:01:40.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":6577,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects supplemental annual equity awards due to an administrative error in the calculations used to determine the original number of shares underlying the annual equity awards."},{"field":"shares","element":"transactionShares","label":"F2","text":"Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units (\"RSUs\") shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events."}],"balance_after":7104320,"source":{"system":"sec-edgar","filing":"0001437749-24-008575","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924008575/rdgdoc.xml","form_type":"4"}},{"id":1642900,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":94298,"kind":"person","name":"Wong Alvin F","position":1,"cik":"0001868855","reported_name":"Wong Alvin F","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T23:03:11.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":59946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date."}],"balance_after":59946,"derivative":{"exercise_price":6.36,"expiration_date":"2034-02-11","underlying":"Common Stock","underlying_shares":59946},"source":{"system":"sec-edgar","filing":"0001437749-24-004218","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924004218/rdgdoc.xml","form_type":"4"}},{"id":1642899,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":94298,"kind":"person","name":"Wong Alvin F","position":1,"cik":"0001868855","reported_name":"Wong Alvin F","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-02-14T23:03:11.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":43307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date."}],"balance_after":141241,"source":{"system":"sec-edgar","filing":"0001437749-24-004218","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924004218/rdgdoc.xml","form_type":"4"}},{"id":1642898,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T23:01:43.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":59946,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date."}],"balance_after":59946,"derivative":{"exercise_price":6.36,"expiration_date":"2034-02-11","underlying":"Common Stock","underlying_shares":59946},"source":{"system":"sec-edgar","filing":"0001437749-24-004216","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924004216/rdgdoc.xml","form_type":"4"}},{"id":1642897,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31418,"kind":"person","name":"NOUGUES MAXIMO F","position":1,"cik":"0001758507","reported_name":"NOUGUES MAXIMO F","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-14T23:01:43.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":43307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date."}],"balance_after":171973,"source":{"system":"sec-edgar","filing":"0001437749-24-004216","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924004216/rdgdoc.xml","form_type":"4"}},{"id":1642896,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T22:58:48.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":222573,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Subject to Optionee's continued status as an Employee of the Company, Options shall vest and become exercisable with respect to one-fourth (1/4th) of the Shares (as defined in the Plan) subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events."}],"balance_after":222573,"derivative":{"exercise_price":6.36,"expiration_date":"2034-02-11","underlying":"Common Stock","underlying_shares":222573},"source":{"system":"sec-edgar","filing":"0001437749-24-004211","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924004211/rdgdoc.xml","form_type":"4"}},{"id":1642895,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-02-14T22:58:48.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":160796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Subject to Grantee's continued status as an Employee of the Company, the Restricted Stock Units (\"RSUs\") shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to acceleration in certain events."}],"balance_after":7097743,"source":{"system":"sec-edgar","filing":"0001437749-24-004211","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924004211/rdgdoc.xml","form_type":"4"}},{"id":1642894,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T22:54:09.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":52452,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date."}],"balance_after":52452,"derivative":{"exercise_price":6.36,"expiration_date":"2034-02-11","underlying":"Common Stock","underlying_shares":52452},"source":{"system":"sec-edgar","filing":"0001437749-24-004207","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924004207/rdgdoc.xml","form_type":"4"}},{"id":1642893,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31420,"kind":"person","name":"HUNT DOUGLAS M","position":1,"cik":"0001727172","reported_name":"HUNT DOUGLAS M","relationship":{"officer":true,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2024-02-14T22:54:09.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":37894,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date."}],"balance_after":141213,"source":{"system":"sec-edgar","filing":"0001437749-24-004207","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924004207/rdgdoc.xml","form_type":"4"}},{"id":1643354,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":83367,"kind":"person","name":"Ludwig Jeffrey Jerome","position":1,"cik":"0001807133","reported_name":"Ludwig Jeffrey Jerome","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-14T18:00:24.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":37466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options shall vest and become exercisable with respect to one-fourth (1/4th) of the shares subject thereto on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Optionee's continued service with the Company through the applicable vesting date."}],"balance_after":37466,"derivative":{"exercise_price":6.36,"expiration_date":"2034-02-11","underlying":"Common Stock","underlying_shares":37466},"source":{"system":"sec-edgar","filing":"0001437749-24-004214","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1807133/000143774924004214/rdgdoc.xml","form_type":"4"}},{"id":1643353,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":83367,"kind":"person","name":"Ludwig Jeffrey Jerome","position":1,"cik":"0001807133","reported_name":"Ludwig Jeffrey Jerome","relationship":{"officer":true,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-02-14T18:00:24.000Z","date":"2024-02-12","kind":"grant","planned":false,"acquired":true,"shares":27067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents Restricted Stock Units (\"RSUs\") that shall vest with respect to one-fourth (1/4th) of the RSUs on each of July 1, 2024, January 1, 2025, July 1, 2025 and January 1, 2026, subject to the Grantee's continued service with the Company through the applicable vesting date."}],"balance_after":127037,"source":{"system":"sec-edgar","filing":"0001437749-24-004214","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1807133/000143774924004214/rdgdoc.xml","form_type":"4"}},{"id":1681483,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":94298,"kind":"person","name":"Wong Alvin F","position":1,"cik":"0001868855","reported_name":"Wong Alvin F","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-01-10T21:41:48.000Z","date":"2023-12-04","kind":"sale","planned":true,"acquired":false,"shares":280,"price":3.7608,"value":1053.024,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.75 to $3.8401, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":97934,"source":{"system":"sec-edgar","filing":"0001437749-24-001115","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924001115/rdgdoc.xml","form_type":"4"}},{"id":1685390,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":94298,"kind":"person","name":"Wong Alvin F","position":1,"cik":"0001868855","reported_name":"Wong Alvin F","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-01-06T00:03:16.000Z","date":"2024-01-03","kind":"sale","planned":true,"acquired":false,"shares":7733,"price":4.4859,"value":34689.4647,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.3601 to $4.7101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":98214,"source":{"system":"sec-edgar","filing":"0001437749-24-000776","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924000776/rdgdoc.xml","form_type":"4"}},{"id":1685389,"issuer":{"id":5478,"kind":"organization","name":"PUMA BIOTECHNOLOGY, INC.","symbol":"PBYI"},"owners":[{"id":31421,"kind":"person","name":"AUERBACH ALAN H","position":1,"cik":"0001358285","reported_name":"AUERBACH ALAN H","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2024-01-05T23:56:33.000Z","date":"2024-01-03","kind":"sale","planned":true,"acquired":false,"shares":41396,"price":4.4859,"value":185698.3164,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Adoption date of referenced 10b5-1(c) sell to cover program is: 12-17-2020."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.3601 to $4.7101, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":6936947,"source":{"system":"sec-edgar","filing":"0001437749-24-000770","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401667/000143774924000770/rdgdoc.xml","form_type":"4"}}],"next_cursor":"2024-01-05T23:56:33.000000Z,1685389"}